Softwr

AI · head to head

LatchBio vs Play.ht

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Rated
-
Full reviewWebsite
P

Play.ht

AI

Ultra-realistic AI voice generator

From
Free
Rated
-
Full reviewWebsite

The short version

  • Only Play.ht has a free tier, so it costs nothing to try first.
  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; Play.ht the vendor's own pricing FAQ as captured by the Internet Archive on 20 January 2022 states words do not roll over between subscription cycles and reset each renewal, that payments already made are non-refundable, and that running out of words requires a separate one-time purchase; no dollar figures appear in this capture but the mechanism is stated plainly by the vendor
  • They diverge on capability: LatchBio covers Agent driven analysis, Play.ht covers 900+ voices.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and Play.ht actually diverge.

Attributes where LatchBio and Play.ht differ
AttributeLatchBioPlay.ht
Starting priceOn requestFree
Pricing modelquotefreemium
Free tierNoYes
PlatformsWebWeb, Api
FoundedUnknown2014

Identical on both: user rating (Not yet rated), category (AI).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in Play.ht

  • 900+ voices
  • 142 languages
  • Voice cloning
  • Real-time streaming
  • API access
  • WordPress plugin
  • Podcast hosting
  • Web support

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Play.ht
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Play.ht
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Play.ht
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Play.ht

Play.ht

  • ai tools managementnot LatchBio
  • Workflow automationnot LatchBio
  • Reportingnot LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

Play.ht

  • The vendor's own pricing FAQ as captured by the Internet Archive on 20 January 2022 states words do not roll over between subscription cycles and reset each renewal, that payments already made are non-refundable, and that running out of words requires a separate one-time purchase; no dollar figures appear in this capture but the mechanism is stated plainly by the vendor

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Play.ht

Free
  • FreeFree
    • 2,500 words/month
    • Standard voices
  • Creator$31/month
    • Unlimited words
    • Voice cloning
  • Pro$99/month
    • Commercial license
    • API access

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.
LatchBio review

Choose Play.ht if

  • You need 900+ voices.
  • You want to start without paying.
  • You work on Web, Api.
  • You also want 142 languages.
Play.ht review

Questions people ask

Is LatchBio or Play.ht better?
Neither clearly leads. LatchBio starts at On request and Play.ht at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or Play.ht?
Play.ht has a free tier; the other does not. Paid plans start at On request for LatchBio and Free for Play.ht.
Does LatchBio or Play.ht run on more platforms?
LatchBio runs on Web. Play.ht runs on Web, Api.
Can I use Play.ht for free?
Yes. Play.ht has a free tier, so you can try it without paying. LatchBio starts at On request.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what Play.ht is typically brought in for.
What can LatchBio do that Play.ht cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals. Play.ht covers 900+ voices, 142 languages, Voice cloning, Real-time streaming.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Share

Related pages

More on LatchBio

More on Play.ht

Keep looking

Other head to heads